Fresenius Medical Care AG & Co. KGaA - Asset Resilience Ratio

Latest as of March 2026: 1.22%

Fresenius Medical Care AG & Co. KGaA (FMEA) has an Asset Resilience Ratio of 1.22% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€384.20 Million
≈ $449.17 Million USD Cash + Short-term Investments

Total Assets

€31.47 Billion
≈ $36.79 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Fresenius Medical Care AG & Co. KGaA's Asset Resilience Ratio has changed over time. Check Fresenius Medical Care AG & Co. KGaA strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Fresenius Medical Care AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Fresenius Medical Care AG & Co. KGaA market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €384.20 Million 1.22%
Total Liquid Assets €384.20 Million 1.22%

Asset Resilience Insights

  • Limited Liquidity: Fresenius Medical Care AG & Co. KGaA maintains only 1.22% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Fresenius Medical Care AG & Co. KGaA Industry Peers by Asset Resilience Ratio

Compare Fresenius Medical Care AG & Co. KGaA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Extendicare Inc
TO:EXE
Medical Care Facilities 32.62%
Chularat Hospital Public Company Limited
BK:CHG-R
Medical Care Facilities 0.88%
CareRx Corp
TO:CRRX
Medical Care Facilities 5.50%
P3 Health Partners Inc
NASDAQ:PIII
Medical Care Facilities 402.86%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%
Freedom Care Group Holdings Ltd
AU:FCG
Medical Care Facilities 0.39%

Annual Asset Resilience Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Fresenius Medical Care AG & Co. KGaA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.77% €238.77 Million
≈ $279.15 Million
€31.00 Billion
≈ $36.24 Billion
-0.11pp
2024-12-31 0.88% €295.63 Million
≈ $345.62 Million
€33.57 Billion
≈ $39.24 Billion
+0.48pp
2023-12-31 0.40% €136.29 Million
≈ $159.33 Million
€33.93 Billion
≈ $39.67 Billion
-0.07pp
2022-12-31 0.48% €169.98 Million
≈ $198.73 Million
€35.75 Billion
≈ $41.80 Billion
+0.08pp
2021-12-31 0.40% €136.36 Million
≈ $159.42 Million
€34.37 Billion
≈ $40.18 Billion
-0.11pp
2020-12-31 0.51% €161.69 Million
≈ $189.03 Million
€31.69 Billion
≈ $37.05 Billion
+0.11pp
2019-12-31 0.40% €133.32 Million
≈ $155.87 Million
€32.93 Billion
≈ $38.50 Billion
+0.03pp
2018-12-31 0.38% €99.59 Million
≈ $116.43 Million
€26.24 Billion
≈ $30.68 Billion
+0.37pp
2017-12-31 0.01% €3.48 Million
≈ $4.07 Million
€24.03 Billion
≈ $28.09 Billion
-0.97pp
2016-12-31 0.98% €251.32 Million
≈ $293.82 Million
€25.61 Billion
≈ $29.94 Billion
--
pp = percentage points

About Fresenius Medical Care AG & Co. KGaA

F:FMEA Germany Medical Care Facilities
Market Cap
$13.69 Billion
€11.71 Billion EUR
Market Cap Rank
#2250 Global
#467 in Germany
Share Price
€21.80
Change (1 day)
+2.83%
52-Week Range
€17.70 - €23.60
All Time High
€37.68
About

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more